February 1st, 2008 - Volume 47 - Issue 2 - Contributor Index

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Author:
Walsh, John MD

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

Author:
Wu, Albert W MD